HomeCYCN • NASDAQ
add
Cyclerion Therapeutics Inc
Previous close
$3.35
Day range
$3.23 - $3.62
Year range
$1.27 - $9.47
Market cap
11.07M USD
Avg Volume
15.71K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
CNBC
54 minutes ago
S&P 500 stock futures rise after Microsoft, Meta post earnings beats: Live updates
3.38%
CNN
6 hours ago
S&P 500, Dow close out April in the red as economy contracts for first time since 2022
0.15%
0.35%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.81M | — |
Operating expense | 1.30M | — |
Net income | 530.00K | — |
Net profit margin | 29.35 | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.23M | -57.31% |
Total assets | 9.58M | -28.41% |
Total liabilities | 725.00K | -65.24% |
Total equity | 8.85M | — |
Shares outstanding | 2.55M | — |
Price to book | 0.96 | — |
Return on assets | 13.59% | — |
Return on capital | 14.72% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 530.00K | — |
Cash from operations | 360.00K | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | 360.00K | — |
Free cash flow | 143.75K | — |
About
Founded
2018
Website
Employees
1
